Women’s health is a new focal point for investors. More research and more investment dollars are going into solving healthcare challenges that are specific to women such as breast cancer and ovarian cancer, fertility, pregnancy, birthing, and menopause. Some healthcare issues disproportionately affect women like infant care, but others such as heart disease have not had solutions developed which meaningfully consider gender…
Women’s health-focused biotech company ObsEva has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for linzagolix for the treatment of uterine fibroids. Uterine fibroids are common benign tumors of the muscular tissue of the uterus. Uterine fibroids affect women of childbearing age and can vary in size from undetectable to large bulky masses. Few long-term medical…
Danish eco-startup LastObject is breaking into the feminine hygiene market with its newest product LastPad, a reusable sanitary pad that aims to reduce the environmental impact of period products and provide a more affordable, comfortable, and healthy alternative for women. In the US alone, approximately 19 billion single-use feminine hygiene products are thrown out each year, the vast majority of which end…
Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, has received FDA clearance for Sonata System 2.2, which provides new benefits for facilities, physicians and patients. These benefits include a 20% reduction in the smallest ablation size setting, which greatly increases the ability to treat fibroids in tighter anatomical locations, new software advances that…
Koble, a community-driven famtech startup with the goal to support moms and dads on their parenting journey, has raises $1M led by Garage capital. Other participants in the round include Panache Ventures as well as a number of angel investors. Koble was founded in January 2021 by Swati Matta with the goal to connect parents and health experts. In a nutshell the…
Biotech company Progenity has announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,112,403 for assessment of preeclampsia using assays for free and dissociated placental growth factor to the company. The patent is directed to methods, compositions, and kits for detecting and measuring free and dissociated placental growth factor (PlGF) levels in biological samples. PlGF is…
Proov, a science-based hormone testing company, has received patent issue notification for its third utility patent, protecting the use of a LH test to identify the opening of the fertile window and the later use of a separate PdG test to identify the closing of the fertile window. The patented method protects uses associated with Proov’s soon to be announced app platform,…
Only days after Telehealth company Hims & Hers announced a focus on women’s and mental health, the company is now expanding its offering with support for urinary tract health. Core to this launch are the new D-Mannose dietary supplement powder packets, that are available on ForHers.com. “Roughly 3 or 4 in 10 women who experience an initial urinary tract infection (UTI) will…
